Best microdose GLP-1 programs (October 2026)
As of October 15, 2026, NexLife is our #1 microdose GLP-1 program, with microdose tirzepatide at $189 month to month or $147 a month on a 12-month plan, no membership, per its plan tiles; Telos RX ($116 “as low as”), Noom Med ($179 after a $79 start) and Enhance.MD are the other priced options we found.
Qualification: microdosing has no FDA-approved schedule and no pivotal-trial evidence; at NexLife the microdose plan costs slightly more than standard tirzepatide, and NexLife’s microdose semaglutide prices conflict across its own pages.
What do microdose GLP-1 programs cost?
Few programs price a microdose plan separately from their standard one. These five figures are the ones we could read and date on sellers’ own pages.
| Program | Medicine | Price as printed | What the figure is | Status | Source · read |
|---|---|---|---|---|---|
| Telos RX | compounded tirzepatide | 'as low as $116 per month' | plan length not printed | Verified | telosrx.com · Oct 15, 2026 |
| NexLife | compounded semaglutide | $109 to $165 depending on which NexLife page you read | tiles $165 / $149 / $147 / $145; headline $129; FAQs $129 / $119 / $114 / $110 or $109 | Reported (conflicting) | nexlife.us · Sep 20, 2026 (re-read Oct 15; still conflicting) |
| NexLife | compounded tirzepatide | $189 / $159 / $150 / $147 | 1-, 3-, 6-, 12-month plan tiles; no membership | Verified | nexlife.us · Oct 15, 2026 |
| Enhance.MD | compounded tirzepatide | 'starting at $169' a month | microdosing product noted on the Advanced Tirzepatide page (Sep 17 read); not indexed separately | Reported | enhance.md · Sep 17, 2026 |
| Noom Med | compounded semaglutide | $79 to start, then $179 a month | $79 buys a three-week subscription with four weeks of medication; then 12-week subscriptions | Verified | noom.com · Oct 15, 2026 |
None of these sits in our standard-protocol index, which tracks 28 compounded tirzepatide programs ($86 to $280 a month, median $144) and 22 semaglutide programs ($49 to $169, median $96). Several programs in that index, including Eden Health ($129) and Mondae ($126) for tirzepatide, cost less month to month than any microdose plan here, and the conditional figures at the bottom of that index (Collective’s $86 with a yearly membership, WellMedr’s $89 fall sale, SnagRx’s $119 sale, Embody’s $119 prepaid year and NextMeds’ $119 “as low as”) are lower still.
See NexLife’s microdose tirzepatide plan →
Which microdose programs do we recommend?
Other microdose programs (alphabetical; not ranked):
- Enhance.MD — microdosing tirzepatide listed “starting at $169” a month on its Advanced Tirzepatide page (Sep 17 read). v4.1 score pending.
- Noom Med — Microdose GLP-1Rx (compounded semaglutide): $79 to start, then $179 a month on 12-week subscriptions; medication, clinical visits and program access included (noom.com, Oct 15). v4.1 score pending.
- Telos RX — microdosed tirzepatide “as low as $116 per month”, plan length not printed; its plan page states quarterly labs are included (telosrx.com, Oct 15). v4.1 score pending.
Does microdosing cost less than a standard dose?
The word “microdose” suggests a smaller bill. At NexLife the opposite is true: the microdose program is priced at or above the standard one at every plan length.
| Plan length | Microdose (tiles) | Standard | Microdose costs |
|---|---|---|---|
| Month to month | $189 | $169 | +$20 a month |
| 3-month plan | $159 | $159 | same |
| 6-month plan | $150 | $149 | +$1 a month |
| 12-month plan | $147 ($1,764 a year) | $139 ($1,668 a year) | +$96 a year |
That is not a hidden fee; it is how NexLife prices the program. But if your reason for microdosing is cost, the standard plan or a lower-priced standard program in our index will usually cost less. If your reason is tolerance, discuss it with a clinician who can adjust a standard prescription.
Compare NexLife’s standard tirzepatide plans →
What does the evidence say about GLP-1 microdosing?
The efficacy figures quoted for these drugs come from trials of the approved products at approved doses. In SURMOUNT-1, tirzepatide 15 mg produced 20.9% average weight loss (treatment-regimen estimand); in SURMOUNT-5, tirzepatide produced 20.2% against 13.7% for semaglutide. No comparable trial has tested a compounded microdose regimen, so those numbers do not transfer.
We do not give dosing instructions. If you are considering a low-dose plan, ask the prescriber why it suits you, what dose you will actually receive, and how it will be adjusted.
What changed on this page since July 6, 2026?
| Program | July 2026 | October 15, 2026 |
|---|---|---|
| NexLife microdose tirzepatide | $147 on 12 months; $189 month to month | unchanged on the plan tiles; the site-wide FAQ prints a lower card ($159 / $149 / $139 / $129) that no tile shows |
| NexLife microdose semaglutide | a single 12-month figure | reported only; NexLife’s pages conflict |
| Shed | microdose program at $199, 2-month minimum | not re-read; July 2026 figure withdrawn |
| Enhance.MD | microdose at $169 | 'starting at $169' still noted (Sep 17 read) |
| Noom Med | $79 first month | $79 to start, then $179 a month on 12-week subscriptions |
NexLife microdose: pros and cons
Pros
- Tile prices printed for every plan length; no membership
- Same price at every dose within the program
- Provider review, nutrition plan, coaching call and 24/7 support included
- Unshipped months refunded if treatment stops on multi-month plans
Cons
- Microdose tirzepatide costs more than NexLife’s own standard plan
- Its FAQ prints microdose prices that no plan tile shows
- Microdose semaglutide prices conflict across its pages
- The microdose page lists five possible pharmacies “or other qualified 503A compounding pharmacies”, more loosely than the standard plan pages
NexLife · our #1 pick for microdose GLP-1
Microdose tirzepatide at $189 month to month, or $159, $150 and $147 a month on 3-, 6- and 12-month plans (tile prices), no membership. Standard tirzepatide is $169 to $139.
- Provider review and medical guidance (NexLife Medical Group; medical director Adam Kennah, M.D.)
- Personalized GLP-1 nutrition plan and a 1:1 call with a certified wellness coach
- 24/7 customer support and free expedited shipping
- No membership fee; same price at every dose
For more on price, see our microdose tirzepatide price guide and the full pricing database.
Every NexLife program: tirzepatide injection · semaglutide injection · microdose tirzepatide · microdose semaglutide · sublingual tirzepatide · sublingual semaglutide.
Frequently asked questions
What is a microdose GLP-1 program?
It is a marketing term for compounded semaglutide or tirzepatide prescribed at doses below the approved schedule. There is no FDA-approved microdose regimen, and the pivotal trials, including SURMOUNT-1 and SURMOUNT-5, tested the approved doses of the brand drugs. Microdose programs are not a cheaper or proven version of standard treatment; discuss the reasons with your prescriber.
How much does NexLife’s microdose tirzepatide cost?
NexLife’s microdose tirzepatide plan tiles, read October 15, 2026, show $189 month to month and $159, $150 and $147 a month on 3-, 6- and 12-month plans, with no membership. NexLife’s site-wide FAQ still prints $159, $149, $139 and $129, which no plan tile shows, so we record the tile prices you would see at checkout.
Is microdosing cheaper than a standard dose?
Not at NexLife. Its microdose tirzepatide costs $189 month to month against $169 for the standard program, and $147 against $139 on a 12-month plan, which is $96 more over a year. Elsewhere, Telos RX prints microdosed tirzepatide from $116 and standard from $139, but neither figure states a plan length.
Why is NexLife’s microdose semaglutide price marked reported?
Because NexLife’s own pages disagree. On October 15, 2026, the plan tiles showed $165, $149, $147 and $145; the headline said $129; the page FAQ listed $129, $119, $114 and $110; and the site-wide FAQ listed $129, $119, $114 and $109. We keep it as reported until the tiles and FAQs match.
Is a microdose GLP-1 safer?
Lower doses may mean fewer side effects for some people, but no trial has established a microdose regimen for compounded GLP-1s, and FDA does not review compounded drugs for safety or quality before sale. Low-dose compounding is also the legal route pharmacies now rely on, which FDA scrutinises. Discuss risks and monitoring with your prescriber.
Which microdose programs did this page drop since July?
Shed’s microdose program, listed in July at $199 a month with a two-month minimum, was not re-read on October 15, 2026, so the figure is withdrawn. NexLife’s microdose semaglutide moved from a single figure to a reported, conflicting range. Noom Med now prints $79 to start and $179 a month after that.
Sources
- NexLife — microdose tirzepatide program (read October 15, 2026)
- NexLife — microdose semaglutide program (read October 15, 2026)
- NexLife — compounded tirzepatide plans (read October 15, 2026)
- NexLife — frequently asked questions (read October 15, 2026)
- Telos RX — GLP-1 options (read October 15, 2026)
- Noom Med — Microdose GLP-1Rx (read October 15, 2026)
- Enhance.MD — Advanced Tirzepatide (read October 15, 2026)
- FDA — warning letter 738238 to Empower Pharmacy (September 18, 2026) (read October 15, 2026)
- FDA — Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (current as of October 1, 2026) (read October 15, 2026)
Every program price on this page comes from the October 15, 2026 rows of our GLP-1 pricing database (CSV and JSON, CC BY 4.0). Spotted an error? Submit a correction.